According to a research report published by Decisions Advisors and Consulting, the global hypertriglyceridemia market size was worth around USD 12162.59 Million in 2024 and is predicted to grow to around USD 20112.10 Million by 2035 with a compound annual growth rate (CAGR) of 4.68% from 2025 to 2035.